SelectScience InterviewsDrug discovery > Lead Discovery
AI accelerates drug discovery and development through data mining
18 Feb 2020
Dr. Jackie Hunter, board member of BenevolentAI, discusses its project that targets glioblastoma and how BenevolentAI has used its technology to come up with new hypotheses for therapeutic agents. This video explains why artificial intelligence (AI) will be transformational for drug discovery and drug development and how it can enhance diagnosis to rapidly detect disease such as cancer.
This interview was filmed at SLAS2020 - watch other highlights from the show here >>
About the company
SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.
